AI-generated summary
The authors describe a single patient with cervical cancer who developed radiation recall reaction after cisplatin and was treated with photobiomodulation therapy. They also report a scoping review of eight included studies, where topical steroids and antihistamines were the main treatments. The authors report an excellent clinical response after one week in the case, and state that the approach appears viable with no reported side effects.
- Participants
- 1
- Studies included
- 8
- Who or what was studied
- A 36-year-old woman with cervical cancer who developed radiation recall reaction after cisplatin, plus studies included in a scoping review of radiation recall reaction treatment.
- Wavelengths
- 660, 808, 450, 590 nm
- Limits stated in the abstract
- The main clinical evidence comes from a single case report, and the abstract does not describe a control group or long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Purpose
Radiation recall reaction (RRR) is a rare and poorly understood phenomenon of tissue radiotoxicity. It is typically triggered by exposure to certain agents, most commonly cytotoxic drugs such as cisplatin. We conducted a scoping review following the methodology proposed by the JBI collaboration and PRISMA-ScR extension. It aimed to map the evidence concerning the treatment of RRR triggered by cisplatin.
Methods
Searches were performed in PubMed/MEDLINE, EMBASE, Web of Science Core Collection, Cochrane Database, and ProQuest™ on March 9, 2025. Eligible studies included primary research, guidelines, and study protocols that addressed RRR as a primary or secondary outcome. A case report was also described.
Results
Eight studies were included, and the main treatments for RRR were topical steroids and antihistamines. A 36-year-old woman with cervical cancer developed intense hyperpigmentation in the inguinal, vulvar, and anal areas, along with anal and labial fissures, dry desquamation in the inguinal region, and vaginal stenosis, 3 days after cisplatin. The diagnosis was RRR affecting mucosa and skin in the intimate region. Photobiomodulation therapy (PBMT) was initiated using lasers emitting wavelengths of 660 and 808 nm for tissue repair in the vulva, anus, and groin, and LEDs emitting 450 nm for vaginal stenosis and 590 nm for hyperpigmentation. Following the first PBMT session, the patient showed an excellent clinical response after 1 week, with a significant reduction in the severity of RRR.
Conclusion
PBMT appears to be a viable, non-invasive, and low-cost treatment option for RRR, with no reported side effects.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 450 nm, 590 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.